Clinical Trial Update: Methylated Genes in Blood as Biomarkers for Advanced Lung Cancer

View source ↗

Summary

A completed clinical trial from Memorial Sloan Kettering Cancer Center evaluating methylated genes in blood as biomarkers for advanced lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Lung Cancer | Status: COMPLETED